$33.06
-2.3%CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.
Chief Information Officer
Executive Vice President of Finance & Chief Financial Officer
Compensation
$1,042,973
Executive Vice President of Human Resources
Executive Vice President of Information Technology & Chief Information Officer
Executive Vice President of Regulatory Affairs, Quality Assurance, Clinical Affairs, & Commercial Operations
Compensation
$542,381
Executive Vice President of Strategy & Corporate Development
Compensation
$574,067
Executive Vice President, General Counsel and Corporate Secretary
President, Chief Executive Officer & Director
Compensation
$1,500,400
Principal Accounting Officer, Vice President & Corporate Controller
Special Advisor
Compensation
$2,051,813
During the last 12 months, insiders have sold $161K worth of CNMD shares, with no buying activity reported.
0
0.00
0
0.00
+0
+$0
0
0.00
0
0.00
+0
+$0
0
0.00
3.8K
161.09K
-161K
-$161K
0
0.00
0
0.00
+0
+$0
No buying activity
Garner Todd W
Officer: Executive Vice President & Cfo
$151K
Glaze Richard
Officer: Chief Information Officer
$11K
Strong bearish signal with $161K net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.
Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.
2 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.
CNMD - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | April 07, 2026 | May 18, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | April 08, 2025 | May 20, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | April 08, 2024 | May 22, 2024 | 2024 | |
DEF 14A DEF 14A N/A | April 11, 2023 | April 11, 2023 | ||
DEF 14A DEF 14A 2022 N/A | April 15, 2022 | May 25, 2022 | 2022 | |
DEF 14A DEF 14A 2021 N/A | April 09, 2021 | May 19, 2021 | 2021 | |
DEF 14A DEF 14A 2019 N/A | April 10, 2020 | December 31, 2019 | 2019 | |
DEF 14A DEF 14A 2018 N/A | April 12, 2019 | December 31, 2018 | 2018 | |
DEF 14A DEF 14A 2018 N/A | April 12, 2018 | May 23, 2018 | 2018 | |
DEF 14A DEF 14A 2017 N/A | April 13, 2017 | May 24, 2017 | 2017 |
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.